<--- Back to Details
First PageDocument Content
Medical equipment / Food law / Hospira / Pharmaceuticals policy / Medical device / Infusion set / Infusion pump / Federal Food /  Drug /  and Cosmetic Act / Center for Devices and Radiological Health / Medicine / Health / Food and Drug Administration
Date: 2011-02-17 14:36:49
Medical equipment
Food law
Hospira
Pharmaceuticals policy
Medical device
Infusion set
Infusion pump
Federal Food
Drug
and Cosmetic Act
Center for Devices and Radiological Health
Medicine
Health
Food and Drug Administration

ro~ Infusion Set Modification Special 510(k) Confidential

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 179,64 KB

Share Document on Facebook

Similar Documents

Pharmacology / Biotechnology / Health care / Recombinant proteins / Pharmaceutical industry / Immunosuppressants / Amgen / Biosimilar / Etanercept / Filgrastim / Hospira / Generic drug

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

DocID: 1rrNB - View Document

Medical research / Health / Clinical research / Drug safety / Pharmaceutical industry / Drug discovery / Food and Drug Administration / Pharmacovigilance / Drug development / Hospira / Phases of clinical research / Covance

ZAI Lab announces appointment of Dr. James Yan as Executive Vice President of Early Development and Drug Safety Shanghai, China – October – Zai Lab Limited (Zai Lab), an innovative biotech company based in Ch

DocID: 1qDbm - View Document

American brands / United States patent law / Hospira / Bivalirudin / On-sale bar

United States Court of Appeals for the Federal Circuit ______________________ THE MEDICINES COMPANY, Plaintiff-Appellant

DocID: 1qAvA - View Document

Business / Economy / Pharmaceutical sciences / American brands / Pfizer / Hospira / Medivation / AbbVie Inc. / Allergan /  Plc / AstraZeneca / Pharmaceutical industry in India / Sanofi

April 29, Sanofi Rebuffed in $9.3 Billion Proposal to Acquire Medivation Sanofi has made a non­binding proposal to acquire Medivation, Inc., a San Francisco­based biopharmaceutical company, for

DocID: 1q9zg - View Document

Dosage forms / Morphinans / Substituted amphetamines / Hospira / Dihydrocodeine / Caspofungin

Products Approved in FY 2010: New Drugs Review Approval Date No. Category Brand Name

DocID: 1pe3I - View Document